Stock AnalizXylem Inc. XYL
Fluid Controls · IPO 2011 · data as of November 13, 2026
Xylem Inc. (XYL) is a industrial company listed in the US with a market value of about $21.6B. In the twelve months to September 30, 2026 it had revenue of $9.1B and net income of $1.1B, a net margin of 11.9%.
Its overall Stock Analiz score is 3.4 out of 5 (good). The strongest part is financial health (4/5); the weakest is value (3/5).
Key numbers: a P/E of 20.8, a price to free cash flow of 23.5, 5-year revenue growth of 13% a year, a 5-year average ROIC of 7%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 34% below the current price.
Score: 3.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- PEG below 1.5
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
- ROE above 15%
- Debt below 3 years of free cash flow
- Share count down over 3 years (buybacks)
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.1B | $9.0B | $8.6B | $7.4B | $5.5B | $5.2B | $4.9B | $5.2B | $5.2B | $4.7B | $3.8B |
| Net income | $1.1B | $957M | $890M | $609M | $355M | $427M | $254M | $401M | $549M | $331M | $260M |
| Free cash flow | $921M | $910M | $942M | $566M | $388M | $330M | $641M | $613M | $349M | $516M | $373M |
| EPS (diluted) | $4.52 | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $1.40 | $2.21 | $3.03 | $1.83 | $1.45 |
| Net margin | 11.9% | 10.6% | 10.4% | 8.3% | 6.4% | 8.2% | 5.2% | 7.6% | 10.5% | 7.0% | 6.9% |
| ROIC | — | 7.1% | 6.4% | 4.9% | 8.9% | 8.2% | 5.2% | 8.5% | 12.1% | 8.3% | 6.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 16 analysts is $125.44, 33% above the current price; targets range from $90.00 to $180.00; the consensus rating is “Buy”; expected EPS is $5.43 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Xylem’s P/E ratio?
About 20.8, based on the last twelve months of diluted earnings per share (forward P/E about 17.1).
Is Xylem stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 34% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Xylem pay a dividend?
Yes. The dividend yield is about 1.83%, and it has paid dividends for 10 years in our data.
Is Xylem a good stock to buy?
We do not give buy or sell advice. Xylem scores 3.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.